A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

New England Journal of Medicine

Volumn 337, Issue 22, 1997, Pages 1576-1583

  McAnulty, J ^a   Halperin, B ^a   Kron, J ^a   Larsen, G ^a   Rait, M ^a   Swenson, R ^a   Floreck, R ^a   Marchant, C ^a   Hamlin, M ^a   Heywood, G ^a   Friedman, P ^a   Stevenson, W ^a   Swat, M ^a   Ganz, L ^a   Sweeney, M ^a   Shea, J ^a   Steinberg, J ^a   Ehlert, F ^a   Zelenkofstke, S ^a   Menchavez Tan, E ^a   De Stefano, M ^a   Brown, G ^a   Karagounis, L ^a   Crandall, B ^a   Osborn, J ^a   Rawling, D ^a   Summers, K ^a   Jacobsen, M ^a   Herre, J ^a   Bernsteim, R ^a   Klevan, L ^a   Cannom, D ^a   Bhandari, A ^a   Lerman, R ^a   Firth, B ^a   Klein, R ^a   Freedman, R ^a   Marks, M ^a   Delahunty, M ^a   Spratt, C ^a   Marinchak, R ^a   Rials, S ^a   Kowey, P ^a   Fillart, R ^a   Hernandez, M ^a   Scher, D ^a   Zukerman, L ^a   Farrell, S ^a   Cross, J ^a   Shewchjik, J ^a   Epstein, A ^a   Cooper, R ^a   Dailey, R ^a   Dailey, S ^a   Kay, G ^a   Plumb, V ^a   Bubien, R ^a   Knotts Dolson, S ^a   McKenna, P ^a   Tidwell, C ^a   Kim, S ^a   Fisher, J ^a   Ferrick, K ^a   Gross, J ^a   Ben Zur, U ^a   Durkin, J ^a   Ferrick, A ^a   Beckman, K ^a   McClelland, J ^a   Gonzalez, M ^a   Widman, L ^a   Lane, R ^a   Deaton, T ^a   Foster, J ^a   Straughan, G ^a   Wade, L ^a   Brodsky, M ^a   Allen, B ^a   Ehrlich, S ^a   Wolff, L ^a   Macari Hinson, M ^a   Coromilas, J ^a   Bigger T , Jr ^a   Livelli F , Jr ^a   Reiffel, J ^a   Hickey, K ^a   Akiyama, T ^a   Daubert, J ^a   Kim, C ^a   Switzer, D ^a   Pande, P ^a   Flynn, D ^a   Keller, M ^a   Ocampo, C ^a   Wahl, K ^a   Vogt, J ^a   Kutalek, S ^a   Hessen, S ^a   Movsowitz, C ^a   more..

^a AVID Clinical Trial Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; RISK ASSESSMENT;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; RESUSCITATION; SOTALOL; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 9844224486     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199711273372202     Document Type: Article

References (32)

1. Cobb LA, Baum RS, Alvarez H III, Schaffer WA. Resuscitation from out-of-hospital ventricular fibrillation: 4 years follow-up. Circulation 1975; 52:Suppl III:III-223-III-235.
2. Goldstein S, Landis JR, Leighton R, et al. Predictive survival models for resuscitated victims of out-of-hospital cardiac arrest with coronary heart disease. Circulation 1985;71:873-80.
3. Maloney J, Masterson M, Khoury D, et al. Clinical performance of the implantable cardioverter defibrillator: electrocardiographic documentation of 101 spontaneous discharges. Pacing Clin Electrophysiol 1991;14:280-5.
4. Lehmann MH, Steinman RT, Schuger CD, Jackson K. The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction. Am J Cardiol 1988;62:803-5.
5. The CASCADE Investigators. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). Am J Cardiol 1993;72:280-7.
6. Mason JW. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 1993;329:452-8.
7. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12.
8. Waldo AL, Camm AJ, deRuyter H, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996;348:7-12. [Erratum, Lancet 1996;348:416.]
9. Julian DG, Camm AJ, Frangin G, et al. Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997;349:667-74. [Erratum, Lancet 1997;349:1180.]
10. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997;349:675-82.
11. Zipes DP, Roberts D. Results of the international study of the implantable pacemaker cardioverter-defibrillator: a comparison of epicardial and endocardial lead systems. Circulation 1995;92:59-65.
12. Winkle RA, Mead RH, Ruder MA, et al. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989; 13:1353-61.
13. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40.
14. Antiarrhythmics versus Implantable Defibrillators (AVID) - rationale, design, and methods. Am J Cardiol 1995;75:470-5.
15. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS): study design and organization. Am J Cardiol 1993; 72:103F-108F.
16. Siebels J, Kuck KH. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J 1994;127:1139-44.
17. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
18. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-56.
19. Dusman RE, Stanton MS, Miles WM, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation 1990;82:51-9.
20. Zipes DP. Implantable cardioverter-defibrillator: lifesaver or a device looking for a disease? Circulation 1994;89:2934-6.
21. Josephson ME, Nisam S. Prospective trials of implantable cardioverter defibrillators versus drugs: are they addressing the right question? Am J Cardiol 1996;77:859-63.
22. Thomas AC, Moser SA, Smutka ML, Wilson PA. Implantable defibrillation: eight years clinical experience. Pacing Clin Electrophysiol 1988;11: 2053-8.
23. Fogoros RN, Elson JJ, Bonnet CA. Actuarial incidence and pattern of occurrence of shocks following implantation of the automatic implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1989;12:1465-73.
24. Greene HL, Richardson DW, Barker AH, et al. Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac-Arrhythmia Pilot Study). Am J Cardiol 1989;63:1-6.
25. Epstein AE, Carlson MD, Fogoros RN, Higgins SL, Venditti FJ Jr. Classification of death in antiarrhythmia trials. J Am Coll Cardiol 1996;27: 433-42.
26. Newman D, Sauve MJ, Herre J, et al. Survival after implantation of the cardioverter defibrillator. Am J Cardiol 1992;69:899-903.
27. Powell AC, Fuchs T, Finkelstein DM, et al. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation 1993;88:1083-92.
28. Saksena S. Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems: the PCD Investigators and participating institutions. Pacing Clin Electrophysiol 1993;16:202-7.
29. Kim SG, Hallstrom A, Love JC, et al. Comparison of clinical characteristics and frequency of implantable defibrillator use between randomized patients in the Antiarrhythmics Vs Implantable Defibrillators (AVID) Trial and nonrandomized registry patients. Am J Cardiol 1997;80:454-7.
30. Kadish AH, Buxton AE, Waxman HL, Flores B, Josephson ME, Marchlinski FE. Usefulness of electrophysiologic study to determine the clinical tolerance of arrhythmia recurrences during amiodarone therapy. J Am Coll Cardiol 1987;10:90-6.
31. Borggrefe M, Haverkamp W, Shenasa M, Hindricks G, Breithardt G. How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the invasive approach. J Cardiovasc Pharmacol 1992;20:Suppl 2:S32-S40.
32. Kim SG, Fogoros RN, Furman S, Connolly SJ, Kuck KH, Moss AJ. Standardized reporting of ICD patient outcome: the report of a North American Society of Pacing and Electrophysiology Policy Conference, February 9-10, 1993. Pacing Clin Electrophysiol 1993;16:1358-62.